Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 2/2019

01-02-2019 | Correction

Correction to: The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer

Authors: Eric A. Miller, Paul F. Pinsky, Dudith Pierre-Victor

Published in: Cancer Causes & Control | Issue 2/2019

Login to get access

Excerpt

In the original publication of the article, the categories of PSA levels among the subpopulation of men diagnosed with prostate cancer were published incorrectly in Table 4. The corrected Table 4 is given in this Correction. …
Metadata
Title
Correction to: The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer
Authors
Eric A. Miller
Paul F. Pinsky
Dudith Pierre-Victor
Publication date
01-02-2019
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2019
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1097-x

Other articles of this Issue 2/2019

Cancer Causes & Control 2/2019 Go to the issue

Original Paper

Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women

Original Paper

The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer

Original paper

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study

Brief Report

Identifying optimal approaches to scale up colorectal cancer screening: an overview of the centers for disease control and prevention (CDC)’s learning laboratory

Original Paper

Rapid increase in endometrial cancer incidence and ethnic differences in New Zealand

Original Paper

Predictors of breast cancer mortality among white and black women in large United States cities: an ecologic study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits